Survival associated with treatment vs observation of localized prostate cancer in elderly men

Area of Science:

• Oncology
• Geriatric Medicine
• Public Health

Background:

• Prostate-specific antigen (PSA) screening has increased prostate cancer diagnoses.
• The benefit of treating low- and intermediate-risk prostate cancer in elderly men remains controversial.

Purpose of the Study:

• To evaluate the association between active treatment (radical prostatectomy or radiation therapy) versus observation.
• To assess overall survival in elderly men diagnosed with low- and intermediate-risk prostate cancer.

Main Methods:

• Retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) Medicare data.
• Included 44,630 men aged 65-80 diagnosed with organ-confined, well- to moderately differentiated prostate cancer (1991-1999).
• Follow-up until December 31, 2002, comparing treatment (n=32,022) vs. observation (n=12,608) using propensity score adjustment.

Main Results:

• The treatment group demonstrated longer 5- and 10-year survival rates compared to the observation group.
• Active treatment was associated with a statistically significant survival advantage (HR, 0.69; 95% CI, 0.66-0.72) after adjustment.
• Treatment benefits were observed across subgroups, including older men (75-80), Black men, and those with low-risk disease.

Conclusions:

• Active treatment appears to offer a survival advantage for elderly men (65-80 years) with low- and intermediate-risk prostate cancer.
• Observational data has limitations regarding selection bias and confounding.
• Results warrant validation through randomized controlled trials comparing management strategies in this population.